Abstract
Nostoc was orally administered to mice to evaluate the possible effects on cyclophosphamide (CY)-induced immunosuppression. The results showed that feeding Nostoc may promote the growth of mice. Meanwhile, spleen and thymus indices, WBC, splenic lymphocyte transformation rate, macrophage phagocytosis, and T-AOC were significantly higher in mice treated with CY + Nostoc than treated with CY. ELISA results showed that Nostoc treatment enhanced the production of IgG, IL-2, IL-4, and IFN-γ in sera of CY-treated mice. In addition, histopathological examination confirmed the biochemical and immunological results, suggesting that Nostoc may be a promising modulator in attenuating CY-induced immunosuppression and oxidative stress.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
